medigraphic.com
Colegio de Medicina Interna de México.

2018, Número 3

<< Anterior Siguiente >>

Med Int Mex 2018; 34 (3)


Efecto en el control glucémico y modificación del tratamiento en pacientes sometidos a cirugía bariátrica

Villena-López EL, Barreda-Zaleta L, Sánchez-Luna JP, Isaías CJO, Rodríguez-Weber FL, Díaz-Greene EJ

Idioma: Español
Referencias bibliográficas: 26
Paginas: 423-434
Archivo PDF: 452.72 Kb.


RESUMEN

La obesidad es el factor de riesgo ambiental más importante de diabetes mellitus tipo 2 y puede encontrarse hasta en 90% de los pacientes. La cirugía bariátrica, también conocida como cirugía metabólica, es cada vez más reconocida como una de las intervenciones más eficaces contra la obesidad y comorbilidades, ayudando a los pacientes a lograr la pérdida de peso sostenible y a mejorar su salud en general. Este artículo revisa los diferentes tipos de cirugía bariátrica, así como su efecto en el control glucémico y en la remisión de la diabetes mellitus 2.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ng M, et al. 2014. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2013;384:766-781.

  2. Flegal KM, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA 2016;315:2284-2291.

  3. Manson JE, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-685.

  4. Calle EE, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097- 1105.

  5. Garrison RJ, Castelli WP. Weight and thirty-year mortality of men in the Framingham Study. Ann Intern Med 1985;103(Pt 2):1006-1009.

  6. Semlitsch T, et al. Long-term effects of weightreducing diets in people with hypertension. 2016. Cochrane Database Syst. Rev. 3: CD008274.

  7. Poirier P, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006;26:968-976.

  8. Kales A, et al. Severe obstructive sleep apnea–I: onset, clinical course, and characteristics. J Chronic Dis 1985;38:419-425.

  9. Davis MA, et al. Sex differences in osteoarthritis of the knee. The role of obesity. Am J Epidemiol 1988;127:1019-1030.

  10. Hartz AJ, et al. The association of obesity with joint pain and osteoarthritis in the HANES data. J Chronic Dis 1986;39:311-319.

  11. Lauby-Secretan B, et al. Body fatness and cancer— viewpoint of the IARC Working Group. N Engl J Med 2016;375:794-798.

  12. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ 2012;31:219-230.

  13. Ponce J, et al. American society for metabolic and bariatric surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg Obes Relat Dis 2015;11:1199-1200.

  14. Ponce J, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis 2016;12:1637-1639.

  15. Ponce J, et al. 2016. American society for metabolic and bariatric surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis 12:1637-1639.

  16. Henrikson V. Can small bowel resection be defended as therapy for obesity? Obes Surg 1994;4:54.

  17. Angrisani L, et al. Bariatric surgery worldwide 2013. Obes Surg 2015;25:1822-1832.

  18. Schauer PR, et al. Laparoscopic gastric bypass surgery: current technique. J Laparoendosc Adv Surg Tech A 2003;13:229-239.

  19. Khan S, et al. Trends in bariatric surgery from 2008 to 2012. Am J Surg 2016;211:1041-1046.

  20. Carrillo-Esper R, Muciño-Bermejo MJ, Tratamiento quirúrgico de la diabetes mellitus tipo 2. Cir Cir 2014;82(2).

  21. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: Clinical outcomes and mechanisms of action. Annu Rev Med 2010;61:393-411.

  22. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009;150:2518-2525.

  23. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-749.

  24. Mason EE. Ileal transposition and enteroglucagon/ GLP-1 in obesity (and diabetic?). Surgery Obes Surg 1999;9:223-228.

  25. Frezza EE. Are we closer in finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg 2004;14:999-1005.

  26. Jirapinyo P, Jin DX, Qazi T, Mishra N, Thompson CC. A Meta-analysis of GLP-1 after Roux-en-Y gastric bypass: Impact of surgical technique and measurement strategy. Obesity Surgery 2017.




2020     |     www.medigraphic.com